Lymph vessels: the forgotten second circulation in health and disease

The lymphatic circulation is still a somewhat forgotten part of the circulatory system. Despite this, novel insights in lymph angiogenesis in health and disease, application of immune markers for lymphatic growth and differentiation and also the introduction of new imaging techniques to visualize the lymphatic circulation have improved our understanding of lymphatic function in both health and disease, especially in the last decade. These achievements yield better understanding of the various manifestations of lymph oedemas and malformations, and also the patterns of lymphovascular spread of cancers. Immune markers that recognize lymphatic endothelium antigens, such as podoplanin, LYVE-1 and Prox-1, can be successfully applied in diagnostic pathology and have revealed (at least partial) lymphatic differentiation in many types of vascular lesions.

[1]  Alexander Crispin,et al.  MR lymphangiography at 3.0 T: correlation with lymphoscintigraphy. , 2012, Radiology.

[2]  Milton V. Marshall,et al.  Imaging of lymph flow in breast cancer patients after microdose administration of a near-infrared fluorophore: feasibility study. , 2008, Radiology.

[3]  K. Alitalo,et al.  FLT4 receptor tyrosine kinase contains seven immunoglobulin-like loops and is expressed in multiple human tissues and cell lines. , 1992, Cancer research.

[4]  Elisabetta Dejana,et al.  Functionally specialized junctions between endothelial cells of lymphatic vessels , 2007, The Journal of experimental medicine.

[5]  P. von der Weid,et al.  Characterization of biosynthesis and modes of action of prostaglandin E2 and prostacyclin in guinea pig mesenteric lymphatic vessels , 2009, British journal of pharmacology.

[6]  D. McDonald,et al.  Markers for Microscopic Imaging of Lymphangiogenesis and Angiogenesis , 2008, Annals of the New York Academy of Sciences.

[7]  K. Nicolaides,et al.  Prox1 is a marker of ectodermal placodes, endodermal compartments, lymphatic endothelium and lymphangioblasts , 2001, Anatomy and Embryology.

[8]  F. Borchard,et al.  Histopathological evaluation of oesophageal carcinoma: The significance of venous invasion , 1991, The British journal of surgery.

[9]  K. Alitalo,et al.  FLT 4 Receptor Tyrosine Kinase Contains Seven Immunoglobulin-like Loops and Is Expressed in Multiple Human Tissues and Cell Lines 1 , 2006 .

[10]  H. Konno,et al.  Influence of age and gender on human lymphatic pumping pressure in the leg. , 2011, Lymphology.

[11]  Dafydd G. Thomas,et al.  Can lymphangiosarcoma be resurrected? A clinicopathological and immunohistochemical study of lymphatic differentiation in 49 angiosarcomas , 2010, Histopathology.

[12]  Gerard L Cote,et al.  Lymph Flow, Shear Stress, and Lymphocyte Velocity in Rat Mesenteric Prenodal Lymphatics , 2006, Microcirculation.

[13]  D. Driman,et al.  Venous invasion in oesophageal adenocarcinoma: enhanced detection using elastic stain and association with adverse histological features and clinical outcomes , 2014, Histopathology.

[14]  Hiroyuki Konno,et al.  Preliminary experience with a novel fluorescence lymphography using indocyanine green in patients with secondary lymphedema. , 2007, Journal of vascular surgery.

[15]  W. Svensson,et al.  Human lymphatic pumping measured in healthy and lymphoedematous arms by lymphatic congestion lymphoscintigraphy , 2007, The Journal of physiology.

[16]  M. Lagunoff,et al.  KSHV Induction of Angiogenic and Lymphangiogenic Phenotypes , 2012, Front. Microbio..

[17]  D. McMillan,et al.  The role of lymphatic and blood vessel invasion in predicting survival and methods of detection in patients with primary operable breast cancer. , 2014, Critical reviews in oncology/hematology.

[18]  N. Ordóñez.  Immunohistochemical Endothelial Markers: A Review , 2012, Advances in anatomic pathology.

[19]  C. Streutker,et al.  Venous Invasion in Colorectal Cancer: Impact of an Elastin Stain on Detection and Interobserver Agreement Among Gastrointestinal and Nongastrointestinal Pathologists , 2013, The American journal of surgical pathology.

[20]  N. Ordóñez.  Podoplanin: A Novel Diagnostic Immunohistochemical Marker , 2006, Advances in anatomic pathology.

[21]  A. Folpe,et al.  Vascular Endothelial Growth Factor Receptor-3 (VEGFR-3): A Marker of Vascular Tumors with Presumed Lymphatic Differentiation, Including Kaposi's Sarcoma, Kaposiform and Dabska-Type Hemangioendotheliomas, and a Subset of Angiosarcomas , 2000, Modern Pathology.

[22]  F. Granata,et al.  Angiogenesis and lymphangiogenesis in inflammatory skin disorders. , 2015, Journal of the American Academy of Dermatology.

[23]  M. Detmar,et al.  An essential role for Prox1 in the induction of the lymphatic endothelial cell phenotype , 2002, The EMBO journal.

[24]  V. Hjortdal,et al.  Human thoracic duct in vitro: diameter-tension properties, spontaneous and evoked contractile activity. , 2010, American journal of physiology. Heart and circulatory physiology.

[25]  A. Irrthum,et al.  Mutations in the VEGFR3 Signaling Pathway Explain 36% of Familial Lymphedema , 2013, Molecular Syndromology.

[26]  S. Ward,et al.  Kit-like immunopositive cells in sheep mesenteric lymphatic vessels , 2002, Cell and Tissue Research.

[27]  A. Friedman,et al.  Hemangiomas and Vascular Malformations: Current Theory and Management , 2012, International journal of pediatrics.

[28]  S. Ylä-Herttuala,et al.  Lymphatic vasculature is increased in heart valves, ischaemic and inflamed hearts and in cholesterol‐rich and calcified atherosclerotic lesions , 2011, European journal of clinical investigation.

[29]  C. M. van der Horst,et al.  Microvascular proliferations in arteriovenous malformations relate to high-flow characteristics, inflammation, and previous therapeutic embolization of the lesion. , 2013, Journal of the American Academy of Dermatology.

[30]  M. Vikkula,et al.  Vascular Anomalies Classification: Recommendations From the International Society for the Study of Vascular Anomalies , 2015, Pediatrics.

[31]  V. Shi,et al.  Inflammation‐Driven Dermal Lymphangiogenesis in Atopic Dermatitis is Associated with CD11b+ Macrophage Recruitment and VEGF‐C Up‐regulation in the IL‐4‐Transgenic Mouse Model , 2012, Microcirculation.

[32]  S. Weiss,et al.  Spindle Cell Hemangioendothelioma: A Low-Grade Angiosarcoma Resembling a Cavernous Hemangioma and Kaposi's Sarcoma , 1986, The American journal of surgical pathology.

[33]  V. Hjortdal,et al.  The human thoracic duct is functionally innervated by adrenergic nerves. , 2014, American journal of physiology. Heart and circulatory physiology.

[34]  G. Groisman,et al.  Detection of venous invasion in surgical specimens of colorectal carcinoma: the efficacy of various types of tissue blocks , 2006, Journal of Clinical Pathology.

[35]  Alexander Marks,et al.  Monoclonal Antibody D2-40, a New Marker of Lymphatic Endothelium, Reacts with Kaposi's Sarcoma and a Subset of Angiosarcomas , 2002, Modern Pathology.

[36]  J. Listgarten,et al.  Lymphovascular Invasion Is Associated With Poor Survival in Gastric Cancer: An Application of Gene-Expression and Tissue Array Techniques , 2006, Annals of Surgery.

[37]  K. Alitalo,et al.  Expression and prognostic value of transcription factor PROX1 in colorectal cancer , 2011, British Journal of Cancer.

[38]  Anatoliy A Gashev,et al.  Contraction‐initiated NO‐dependent lymphatic relaxation: a self‐regulatory mechanism in rat thoracic duct , 2006, The Journal of physiology.

[39]  Timothy M Pawlik,et al.  Tumor size predicts vascular invasion and histologic grade: Implications for selection of surgical treatment for hepatocellular carcinoma , 2005, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[40]  I. Koshima,et al.  Characteristic Indocyanine Green Lymphography Findings in Lower Extremity Lymphedema: The Generation of a Novel Lymphedema Severity Staging System Using Dermal Backflow Patterns , 2011, Plastic and reconstructive surgery.

[41]  K. Alitalo,et al.  Angiogenic responses of vascular endothelial growth factors in periadventitial tissue. , 2003, Human gene therapy.

[42]  D. Kerjaschki,et al.  Lymphatic endothelial progenitor cells contribute to de novo lymphangiogenesis in human renal transplants , 2006, Nature Medicine.

[43]  J. Mulliken,et al.  Vascular anomalies in 5,621 patients: guidelines for referral. , 2011, Journal of pediatric surgery.

[44]  A. Recht,et al.  Lymphatic vessel invasion is an independent prognostic factor for survival in colorectal cancer. , 1989, International journal of radiation oncology, biology, physics.

[45]  A. Scarsbrook,et al.  Pearls and pitfalls of radionuclide imaging of the lymphatic system. Part 2: evaluation of extremity lymphoedema. , 2007, The British journal of radiology.

[46]  Anatoliy A Gashev,et al.  Lymphatic Vessels: Pressure‐ and Flow‐dependent Regulatory Reactions , 2008, Annals of the New York Academy of Sciences.

[47]  I. Frieden,et al.  Vascular malformations: Part I. , 2007, Journal of the American Academy of Dermatology.

[48]  Robert Bittman,et al.  Lymphatic vasculature mediates macrophage reverse cholesterol transport in mice. , 2013, The Journal of clinical investigation.

[49]  M. Miettinen,et al.  Prox1 Transcription Factor as a Marker for Vascular Tumors—Evaluation of 314 Vascular Endothelial and 1086 Nonvascular Tumors , 2012, The American journal of surgical pathology.

[50]  M. Pollheimer,et al.  Intramural and extramural vascular invasion in colorectal cancer , 2012, Cancer.

[51]  C. M. van der Horst,et al.  Presence of a distinct neural component in congenital vascular malformations relates to the histological type and location of the lesion. , 2009, Human pathology.

[52]  N. Mchale.  Lymphatic innervation. , 1990, Blood vessels.

[53]  C. Galambos,et al.  Prox-1 and VEGFR3 Antibodies Are Superior to D2–40 in Identifying Endothelial Cells of Lymphatic Malformations—A Proposal of a New Immunohistochemical Panel to Differentiate Lymphatic from other Vascular Malformations , 2009, Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society.

[54]  R. Skoracki,et al.  A Prospective Analysis of 100 Consecutive Lymphovenous Bypass Cases for Treatment of Extremity Lymphedema , 2013, Plastic and reconstructive surgery.

[55]  G. V. Chaitanya,et al.  Emerging roles of lymphatics in inflammatory bowel disease , 2010, Annals of the New York Academy of Sciences.

[56]  E. M. Renkin.  Some consequences of capillary permeability to macromolecules: Starling's hypothesis reconsidered. , 1986, The American journal of physiology.

[57]  K. Alitalo,et al.  Lymphatic Vessel Insufficiency in Hypercholesterolemic Mice Alters Lipoprotein Levels and Promotes Atherogenesis , 2014, Arteriosclerosis, thrombosis, and vascular biology.

[58]  T. Gao,et al.  Expression of Prox1, D2‐40, and WT1 in spindle cell hemangioma , 2014, Journal of cutaneous pathology.

[59]  S. Weiss,et al.  Kaposiform Hemangioendothelioma of Infancy and Childhood: An Aggressive Neoplasm Associated with Kasabach-Merritt Syndrome and Lymphangiomatosis , 1993, The American journal of surgical pathology.

[60]  D. Jackson,et al.  LYVE-1, a New Homologue of the CD44 Glycoprotein, Is a Lymph-specific Receptor for Hyaluronan , 1999, The Journal of cell biology.

[61]  G. Schaffner,et al.  Podoplanin, novel 43-kd membrane protein of glomerular epithelial cells, is down-regulated in puromycin nephrosis. , 1997, American Journal of Pathology.

[62]  P. Laakkonen,et al.  Lymphatic neoangiogenesis in human kidney transplants is associated with immunologically active lymphocytic infiltrates. , 2004, Journal of the American Society of Nephrology : JASN.

[63]  J. Levick,et al.  Microvascular fluid exchange and the revised Starling principle. , 2010, Cardiovascular research.

[64]  D. Vass,et al.  The value of an elastic tissue stain in detecting venous invasion in colorectal cancer , 2004, Journal of Clinical Pathology.

[65]  D. Zawieja,et al.  Modulation of lymphatic muscle contractility by the neuropeptide substance P. , 2008, American journal of physiology. Heart and circulatory physiology.

[66]  S. Mansour,et al.  The classification and diagnostic algorithm for primary lymphatic dysplasia: an update from 2010 to include molecular findings , 2013, Clinical genetics.

[67]  I. Ellis,et al.  Objective assessment of blood and lymphatic vessel invasion and association with macrophage infiltration in cutaneous melanoma , 2011, Modern Pathology.

[68]  V. Hjortdal,et al.  Identification of Interstitial Cajal-Like Cells in the Human Thoracic Duct , 2012, Cells Tissues Organs.

[69]  David Wu,et al.  Ets-1 Is Required for the Activation of VEGFR3 during Latent Kaposi's Sarcoma-Associated Herpesvirus Infection of Endothelial Cells , 2013, Journal of Virology.

[70]  D. Zawieja,et al.  Intrinsic increase in lymphangion muscle contractility in response to elevated afterload. , 2012, American journal of physiology. Heart and circulatory physiology.

[71]  D. Klimstra,et al.  Biologic Predictors of Survival in Node-Negative Gastric Cancer , 2003, Annals of surgery.

[72]  N. Michels,et al.  A method for demonstrating subserous lymphatics with hydrogen peroxide , 1963, The Anatomical record.

[73]  J. Scallan,et al.  Constriction of isolated collecting lymphatic vessels in response to acute increases in downstream pressure , 2013, The Journal of physiology.

[74]  E. van Marck,et al.  Distinguishing blood and lymph vessel invasion in breast cancer: a prospective immunohistochemical study , 2006, British Journal of Cancer.

[75]  P. Lu,et al.  Prognostic role of lymphatic vessel invasion in early gastric cancer: a retrospective study of 188 cases. , 2010, Surgical oncology.

[76]  R. Jain,et al.  LYVE-1 is not restricted to the lymph vessels: expression in normal liver blood sinusoids and down-regulation in human liver cancer and cirrhosis. , 2001, Cancer research.

[77]  M. Delorenzi,et al.  PROX1 promotes metabolic adaptation and fuels outgrowth of Wnt(high) metastatic colon cancer cells. , 2014, Cell reports.

[78]  K. Alitalo,et al.  Lack of lymphatic vascular specificity of vascular endothelial growth factor receptor 3 in 185 vascular tumors , 1999, Cancer.

[79]  M. Delorenzi,et al.  PROX 1 Promotes Metabolic Adaptation and Fuels Outgrowth of Wnt ( high ) Metastatic Colon Cancer Cells , 2017 .

[80]  D. Jackson,et al.  Distribution of lymphatic vessels in normal and arthritic human synovial tissues , 2003, Annals of the rheumatic diseases.

[81]  M. Detmar,et al.  Lymphatic vessels: new targets for the treatment of inflammatory diseases , 2013, Angiogenesis.

[82]  I. Jacobs,et al.  Detection of tumour lymphovascular space invasion using dual cytokeratin and CD31 immunohistochemistry , 2003, Journal of clinical pathology.

[83]  M. Detmar,et al.  Multifocal lymphangioendotheliomatosis with thrombocytopenia: a newly recognized clinicopathological entity. , 2004, Archives of dermatology.

[84]  M. Mazumdar,et al.  Clinical Relevance of Detection of Lymphovascular Invasion in Primary Melanoma Using Endothelial Markers D2-40 and CD34 , 2011, The American journal of surgical pathology.

[85]  T. Wilson,et al.  Predicting patient survival after pancreaticoduodenectomy for malignancy: histopathological criteria based on perineural infiltration and lymphovascular invasion. , 2010, HPB : the official journal of the International Hepato Pancreato Biliary Association.

[86]  S. Rockson,et al.  New developments in clinical aspects of lymphatic disease. , 2014, The Journal of clinical investigation.

[87]  E. Horning.  The Pathology of Tumours , 1926, Nature.

[88]  K. Alitalo,et al.  Targeting Lymphatic Vessel Activation and CCL21 Production by Vascular Endothelial Growth Factor Receptor-3 Inhibition Has Novel Immunomodulatory and Antiarteriosclerotic Effects in Cardiac Allografts , 2010, Circulation.

[89]  F. Bosman,et al.  Immunohistochemical Expression of Endothelial Markers CD31, CD34, von Willebrand Factor, and Fli-1 in Normal Human Tissues , 2006, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.